GSE183204 ALS HSP70 overexpression 1 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE183204_ALS_HSP70 overexpression_1_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE183204_ALS_HSP70 overexpression_1_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE183204_ALS_HSP70 overexpression_1_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE183204_ALS_HSP70 overexpression_1_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

POU class 3 homeobox 3

Gene

non-coding RNA activated by DNA damage

Gene

TPTE pseudogene 1

Gene

PRKAR1B antisense RNA 1

Gene

INKA2 antisense RNA 1

Gene

lymphocyte antigen 6 family member G6D

Gene

SEPT5-GP1BB readthrough

Gene

DLGAP1 antisense RNA 6

Gene

tripartite motif containing 40

Gene

DEAD/H-box helicase 11 like 2 (pseudogene)

  • Gene

    POU class 3 homeobox 3


  • Gene

    non-coding RNA activated by DNA damage


  • Gene

    TPTE pseudogene 1


  • Gene

    PRKAR1B antisense RNA 1


  • Gene

    INKA2 antisense RNA 1


  • Gene

    lymphocyte antigen 6 family member G6D


  • Gene

    SEPT5-GP1BB readthrough


  • Gene

    DLGAP1 antisense RNA 6


  • Gene

    tripartite motif containing 40


  • Gene

    DEAD/H-box helicase 11 like 2 (pseudogene)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.